Mark P. Burgoon
- Pathology and Forensic Medicine top 2%
- Immunology top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Neurology top 5%
- Oncology
- Co-authors
- Gregory P. OwensDonald H. GildenAlanna RitchieJeffrey L. BennettR. Anthony WilliamsonJohn R. CorboyXiaoli YuDon Gilden
- Topics
- Monoclonal and Polyclonal Antibodies Research (20 papers)Immunotherapy and Immune Responses (9 papers)T-cell and B-cell Immunology (9 papers)
- Journals
- Proceedings of the National Academy of SciencesThe Journal of ImmunologyAnnals of Neurology
- Partner nations
- United StatesAustriaNetherlands
In The Last Decade
Mark P. Burgoon
26 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 61
- Pathology and Forensic Medicine 732
- Immunology 662
- Radiology, Nuclear Medicine and Imaging 321
- Neurology 272
- Oncology 168
Countries citing papers authored by Mark P. Burgoon
This map shows the geographic impact of Mark P. Burgoon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. Burgoon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. Burgoon more than expected).
Fields of papers citing papers by Mark P. Burgoon
This network shows the impact of papers produced by Mark P. Burgoon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. Burgoon. The network helps show where Mark P. Burgoon may publish in the future.
Co-authorship network of co-authors of Mark P. Burgoon
This figure shows the co-authorship network connecting the top 25 collaborators of Mark P. Burgoon. A scholar is included among the top collaborators of Mark P. Burgoon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark P. Burgoon. Mark P. Burgoon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 15 | |
| 2 | 39 | |
| 3 | 40 | |
| 4 | 153 | |
| 5 | 10 | |
| 6 | 29 | |
| 7 | 55 | |
| 8 | 20 | |
| 9 | 12 | |
| 10 | 63 | |
| 11 | 37 | |
| 12 | 70 | |
| 13 | 174 | |
| 14 | 35 | |
| 15 | 12 | |
| 16 | 13 | |
| 17 | 37 | |
| 18 | 12 | |
| 19 | 144 | |
| 20 | 11 |
About Mark P. Burgoon
Mark P. Burgoon is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Pathology and Forensic Medicine, having authored 26 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (20 papers), Immunotherapy and Immune Responses (9 papers) and T-cell and B-cell Immunology (9 papers). The work is most often cited by research in Pathology and Forensic Medicine (732 citations), Immunology (662 citations) and Neurology (272 citations). Mark P. Burgoon has collaborated with scholars based in United States, Austria and Netherlands. Frequent co-authors include Gregory P. Owens, Donald H. Gilden, Alanna Ritchie, Jeffrey L. Bennett, R. Anthony Williamson, John R. Corboy, Xiaoli Yu, Don Gilden, Mary Devlin and Andrew Shearer. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Annals of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.